Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2014-12-15 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DAMPIERRE-SUR-SALON (70180), Haute-Saone
PHARMACIE DE DAMPIERRE : revenue, balance sheet and financial ratios
PHARMACIE DE DAMPIERRE is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DAMPIERRE-SUR-SALON (70180),
this company of category PME
shows in 2022 a revenue of 2.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE DAMPIERRE (SIREN 808394100)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 566 741 €
N/C
N/C
2 107 332 €
2 131 150 €
2 015 805 €
1 931 452 €
Net income
135 277 €
115 461 €
103 915 €
143 088 €
155 138 €
129 219 €
141 642 €
189 245 €
220 269 €
EBITDA
N/C
N/C
229 159 €
N/C
N/C
179 945 €
193 822 €
236 620 €
264 209 €
Net margin
N/C
N/C
4.0%
N/C
N/C
6.1%
6.6%
9.4%
11.4%
Revenue and income statement
In 2024, PHARMACIE DE DAMPIERRE generates positive net income of 135 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 220 k€ -> 135 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
135 277 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 47%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
47.476%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
56.242%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE DAMPIERRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
268.013
198.986
184.162
135.409
136.094
115.627
96.893
68.67
47.476
Financial autonomy
23.454
29.444
31.175
37.448
38.459
40.872
44.038
50.438
56.242
Repayment capacity
4.959
5.696
6.658
6.249
None
None
5.667
None
None
Cash flow / Revenue
12.12%
10.785%
8.127%
7.756%
None%
None%
6.275%
None%
None%
Sector positioning
Debt ratio
47.482024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-12 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE DAMPIERRE (47.48) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
56.24%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+12 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE DAMPIERRE (56.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
5.67 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DE DAMPIERRE (5.67) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 129.46. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
129.46
Liquidity indicators evolution PHARMACIE DE DAMPIERRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
184.379
222.443
214.001
202.04
348.253
266.456
209.915
169.96
129.46
Interest coverage
11.252
8.638
10.882
10.543
None
None
21.568
None
None
Sector positioning
Liquidity ratio
129.462024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average-28 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE DAMPIERRE (129.46) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
21.57x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE DE DAMPIERRE (21.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 34 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 677 days. Excellent situation: suppliers finance 643 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
34 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
677 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE DAMPIERRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
204 000 €
267 759 €
220 681 €
271 909 €
0 €
0 €
290 863 €
0 €
0 €
Inventory turnover (days)
32
32
29
32
0
0
38
0
0
Customer payment term (days)
6
8
6
3
0
55
2
34
34
Supplier payment term (days)
46
41
35
37
0
590
39
716
677
Positioning of PHARMACIE DE DAMPIERRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE DAMPIERRE is estimated at
1 888 566 €
(range 1 315 168€ - 2 825 404€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1315k€1888k€2825k€
1 888 566 €Range: 1 315 168€ - 2 825 404€
NAF 5 année 2024
Valuation method used
Net Income Multiple
135 277 €
×
14.0x
=1 888 567 €
Range: 1 315 168€ - 2 825 404€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE DAMPIERRE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE DAMPIERRE
What is the revenue of PHARMACIE DE DAMPIERRE ?
The revenue of PHARMACIE DE DAMPIERRE in 2022 is 2.6 M€.
Is PHARMACIE DE DAMPIERRE profitable?
Yes, PHARMACIE DE DAMPIERRE generated a net profit of 135 k€ in 2024.
Where is the headquarters of PHARMACIE DE DAMPIERRE ?
The headquarters of PHARMACIE DE DAMPIERRE is located in DAMPIERRE-SUR-SALON (70180), in the department Haute-Saone.
Where to find the tax return of PHARMACIE DE DAMPIERRE ?
The tax return of PHARMACIE DE DAMPIERRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE DAMPIERRE operate?
PHARMACIE DE DAMPIERRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart